NSE
Bharat Rasayan LimitedBHARATRAS
Bharat Rasayan Limited is a leading manufacturer of pharmaceuticals, cosmetics, and food products in India. The company was founded in 1981 and is listed on the National Stock Exchange (NSE).
| Key products | Pharmaceuticals, Cosmetics, Food Products |
|---|---|
| Geography | India, International Markets |
| Competitors | Sun Pharma, Dr. Reddy's Laboratories, Cipla Limited |
AI-generated overview — verify before relying on it.
Net institutional flow
No institutional deals
Institutional buyers
0 in / 0 out
High-impact filings
0 · tilt Neutral
Next corporate action
Bonus 1:1
ex 2025-12-12
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | ATALREAL | +₹5.2 Cr | 159 | — | — | — | — |
| 2 | MOBIKWIK | +₹0.1 Cr | 83 | — | — | — | — |
| 3 | QUADFUTURE | +₹0 Cr | 134 | — | — | — | — |
| 4 | BHARATRASThis | — | — | — | — | — | — |
| 5 | MTNL | +₹0 Cr | 2 | — | — | — | — |
| 6 | GATECH | +₹0 Cr | 8 | — | — | — | — |
| 7 | IRMENERGY | −₹2.2 Cr | 328 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
SWOT
Strengths
- • Established brand with over 40 years of experience
- • Diversified product portfolio across pharmaceuticals, cosmetics, and food products
- • Strong presence in the Indian market with a large customer base
- • Research and development capabilities
Weaknesses
- • Dependence on a few key products for revenue growth
- • High competition in the pharmaceutical sector
- • Regulatory challenges in the Indian market
- • Limited international presence
Opportunities
- • Growing demand for generic medicines in India
- • Expansion into new markets such as Africa and Southeast Asia
- • Diversification into emerging segments like biotechnology
- • Development of innovative products through R&D investments
Threats
- • Competition from low-cost generics in India
- • Regulatory changes affecting the pharmaceutical industry
- • Fluctuations in raw material costs
- • Global health trends shifting towards preventive care over prescription medicines
AI-generated from our data — verify before relying on it.
- 2026-06-10FilingBharat Rasayan Limited has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stShareholding Disclosure
- 2026-06-10Filing BRL FINLEASE LIMITED has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stoShareholding Disclosure
- 2025-12-12ActionBonus 1:1Bonus
- 2025-12-12ActionFace Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 5/- Per ShareSplit
- 2025-09-12ActionDividend - Rs 1.50 Per ShareDividend
- 2024-09-12ActionDividend - Rs 1.50 Per ShareDividend
- 2024-09-12ActionAnnual General MeetingMeeting
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 2Shareholding DisclosureNeutral
a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011.
Source PDF → - 2Shareholding DisclosureNeutral
a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011.
Source PDF →
No bulk/block deals for BHARATRAS in this window.
News & chatter on BHARATRAS
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.